{"transactions":[{"id":1387977,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":86814,"kind":"person","name":"Waltzman Roger J.","position":1,"cik":"0001678987","reported_name":"Waltzman Roger J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-10T16:05:12.000Z","date":"2024-10-09","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in full on April 9, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date."}],"balance_after":75000,"derivative":{"exercise_price":1.105,"expiration_date":"2034-10-09","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-24-040728","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678987/000149315224040728/ownership.xml","form_type":"4"}},{"id":1672646,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":86814,"kind":"person","name":"Waltzman Roger J.","position":1,"cik":"0001678987","reported_name":"Waltzman Roger J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-23T16:15:55.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on January 22, 2025 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on January 22, 2027."}],"balance_after":75000,"derivative":{"exercise_price":1.74,"expiration_date":"2034-01-22","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001493152-24-003449","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678987/000149315224003449/ownership.xml","form_type":"4"}},{"id":1813594,"issuer":{"id":6530,"kind":"organization","name":"Indaptus Therapeutics, Inc."},"owners":[{"id":86814,"kind":"person","name":"Waltzman Roger J.","position":1,"cik":"0001678987","reported_name":"Waltzman Roger J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-07T17:25:41.000Z","date":"2023-08-07","kind":"grant","planned":false,"acquired":true,"shares":90000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to one-third of the total shares on August 7, 2024 and thereafter in equal quarterly installments over the following 24 months, such that the stock option becomes vested and exercisable as to all shares on August 7, 2026."}],"balance_after":90000,"derivative":{"exercise_price":1.85,"expiration_date":"2033-08-07","underlying":"Common Stock","underlying_shares":90000},"source":{"system":"sec-edgar","filing":"0001493152-23-027061","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1678987/000149315223027061/ownership.xml","form_type":"4"}},{"id":2007065,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":86814,"kind":"person","name":"Waltzman Roger J.","position":1,"cik":"0001678987","reported_name":"Waltzman Roger J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2023-02-17T08:00:14.000Z","date":"2023-02-15","kind":"grant","acquired":true,"shares":170000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 15, 2024, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over the following 36 months."}],"balance_after":170000,"derivative":{"exercise_price":0.4812,"expiration_date":"2033-02-14","underlying":"Common Stock","underlying_shares":170000},"source":{"system":"sec-edgar","filing":"0000899243-23-005364","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924323005364/doc4.xml","form_type":"4"}},{"id":2388095,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":86814,"kind":"person","name":"Waltzman Roger J.","position":1,"cik":"0001678987","reported_name":"Waltzman Roger J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-17T08:07:12.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 15, 2023, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over the following 36 months."}],"balance_after":125000,"derivative":{"exercise_price":2.77,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-22-006731","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924322006731/doc4.xml","form_type":"4"}},{"id":2853955,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":86814,"kind":"person","name":"Waltzman Roger J.","position":1,"cik":"0001678987","reported_name":"Waltzman Roger J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See remarks"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-17T17:01:06.000Z","date":"2021-02-15","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 15, 2022, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over the following 36 months."}],"balance_after":125000,"derivative":{"exercise_price":14.05,"expiration_date":"2031-02-15","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0000899243-21-006912","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924321006912/doc4.xml","form_type":"4"}},{"id":3266441,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":86814,"kind":"person","name":"Waltzman Roger J.","position":1,"cik":"0001678987","reported_name":"Waltzman Roger J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-02-18T21:59:40.000Z","date":"2020-02-14","kind":"grant","acquired":true,"shares":120000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 14, 2021, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over 36 months."}],"balance_after":120000,"derivative":{"exercise_price":14.5,"expiration_date":"2030-02-14","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0000899243-20-004990","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924320004990/doc4.xml","form_type":"4"}},{"id":3641456,"issuer":{"id":85987,"kind":"organization","name":"Molecular Templates, Inc.","symbol":"MTEM"},"owners":[{"id":86814,"kind":"person","name":"Waltzman Roger J.","position":1,"cik":"0001678987","reported_name":"Waltzman Roger J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-02-21T16:56:39.000Z","date":"2019-02-19","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the option shall vest on February 19, 2020, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over 36 months."}],"balance_after":175000,"derivative":{"exercise_price":4.8,"expiration_date":"2029-02-19","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0000899243-19-004401","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1183765/000089924319004401/doc4.xml","form_type":"4"}},{"id":4513961,"issuer":{"id":8387,"kind":"organization","name":"Jaguar Health, Inc."},"owners":[{"id":86814,"kind":"person","name":"Waltzman Roger J.","position":1,"cik":"0001678987","reported_name":"Waltzman Roger J.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-12-21T19:41:07.000Z","date":"2016-12-19","kind":"grant","acquired":true,"shares":2866,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Granted pursuant to the Issuer's 2014 Equity Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Vests in equal monthly installments, beginning on January 19, 2017, such that it is vested in full on the 3-year anniversary of the grant date."}],"balance_after":2866,"derivative":{"exercise_price":0.74,"expiration_date":"2026-12-19","underlying":"Common Stock","underlying_shares":2866},"source":{"system":"sec-edgar","filing":"0001104659-16-163180","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1585608/000110465916163180/a4.xml","form_type":"4"}}]}